These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 34417456)

  • 1. MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer.
    Kalogirou C; Linxweiler J; Schmucker P; Snaebjornsson MT; Schmitz W; Wach S; Krebs M; Hartmann E; Puhr M; Müller A; Spahn M; Seitz AK; Frank T; Marouf H; Büchel G; Eckstein M; Kübler H; Eilers M; Saar M; Junker K; Röhrig F; Kneitz B; Rosenfeldt MT; Schulze A
    Nat Commun; 2021 Aug; 12(1):5066. PubMed ID: 34417456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis.
    Neuwirt H; Bouchal J; Kharaishvili G; Ploner C; Jöhrer K; Pitterl F; Weber A; Klocker H; Eder IE
    Cell Commun Signal; 2020 Jan; 18(1):11. PubMed ID: 31980029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SQLE induces epithelial-to-mesenchymal transition by regulating of miR-133b in esophageal squamous cell carcinoma.
    Qin Y; Zhang Y; Tang Q; Jin L; Chen Y
    Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):138-148. PubMed ID: 28069586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of squalene epoxidase linking with PI3K/AKT signaling pathway suppresses endometrial cancer.
    Ma L; Huang W; Liang X; Bai G; Wang X; Jiang H; Xin Y; Hu L; Chen X; Liu C
    Cancer Sci; 2023 Sep; 114(9):3595-3607. PubMed ID: 37438885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squalene Epoxidase Metabolic Dependency Is a Targetable Vulnerability in Castration-Resistant Prostate Cancer.
    Shangguan X; Ma Z; Yu M; Ding J; Xue W; Qi J
    Cancer Res; 2022 Sep; 82(17):3032-3044. PubMed ID: 35767703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chemical biology screen identifies a vulnerability of neuroendocrine cancer cells to SQLE inhibition.
    Mahoney CE; Pirman D; Chubukov V; Sleger T; Hayes S; Fan ZP; Allen EL; Chen Y; Huang L; Liu M; Zhang Y; McDonald G; Narayanaswamy R; Choe S; Chen Y; Gross S; Cianchetta G; Padyana AK; Murray S; Liu W; Marks KM; Murtie J; Dorsch M; Jin S; Nagaraja N; Biller SA; Roddy T; Popovici-Muller J; Smolen GA
    Nat Commun; 2019 Jan; 10(1):96. PubMed ID: 30626880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis.
    Li C; Wang Y; Liu D; Wong CC; Coker OO; Zhang X; Liu C; Zhou Y; Liu Y; Kang W; To KF; Sung JJ; Yu J
    Gut; 2022 Nov; 71(11):2253-2265. PubMed ID: 35232776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squalene Epoxidase Induces Nonalcoholic Steatohepatitis Via Binding to Carbonic Anhydrase III and is a Therapeutic Target.
    Liu D; Wong CC; Zhou Y; Li C; Chen H; Ji F; Go MYY; Wang F; Su H; Wei H; Cai Z; Wong N; Wong VWS; Yu J
    Gastroenterology; 2021 Jun; 160(7):2467-2482.e3. PubMed ID: 33647280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squalene epoxidase-induced cholesteryl ester accumulation promotes nasopharyngeal carcinoma development by activating PI3K/AKT signaling.
    Li L; Zhang Q; Wang X; Li Y; Xie H; Chen X
    Cancer Sci; 2020 Jul; 111(7):2275-2283. PubMed ID: 32314495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target.
    Liu D; Wong CC; Fu L; Chen H; Zhao L; Li C; Zhou Y; Zhang Y; Xu W; Yang Y; Wu B; Cheng G; Lai PB; Wong N; Sung JJY; Yu J
    Sci Transl Med; 2018 Apr; 10(437):. PubMed ID: 29669855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squalene epoxidase promotes the chemoresistance of colorectal cancer via (S)-2,3-epoxysqualene-activated NF-κB.
    Liu Q; Zhang Y; Li H; Gao H; Zhou Y; Luo D; Shan Z; Yang Y; Weng J; Li Q; Yang W; Li X
    Cell Commun Signal; 2024 May; 22(1):278. PubMed ID: 38762737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer.
    Siu MK; Chen WY; Tsai HY; Chen HY; Yin JJ; Chen CL; Tsai YC; Liu YN
    Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):172-178. PubMed ID: 28220803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of SQLE Contributes to Poor Survival in Head and Neck Squamous Cell Carcinoma.
    Li J; Yang T; Wang Q; Li Y; Wu H; Zhang M; Qi H; Zhang H; Li J
    Int J Biol Sci; 2022; 18(9):3576-3591. PubMed ID: 35813482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.
    Chu M; Chang Y; Guo Y; Wang N; Cui J; Gao WQ
    PLoS One; 2015; 10(4):e0116197. PubMed ID: 25860954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer.
    Gui B; Hsieh CL; Kantoff PW; Kibel AS; Jia L
    PLoS One; 2017; 12(9):e0184166. PubMed ID: 28886115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis.
    Lin TH; Lee SO; Niu Y; Xu D; Liang L; Li L; Yeh SD; Fujimoto N; Yeh S; Chang C
    J Biol Chem; 2013 Jul; 288(27):19359-69. PubMed ID: 23687298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p66Shc protein through a redox mechanism enhances the progression of prostate cancer cells towards castration-resistance.
    Miller DR; Ingersoll MA; Chatterjee A; Baker B; Shrishrimal S; Kosmacek EA; Zhu Y; Cheng PW; Oberley-Deegan RE; Lin MF
    Free Radic Biol Med; 2019 Aug; 139():24-34. PubMed ID: 31100478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of Squalene Epoxidase by Cholesterol Accumulation Accelerates Colorectal Cancer Progression and Metastasis.
    Jun SY; Brown AJ; Chua NK; Yoon JY; Lee JJ; Yang JO; Jang I; Jeon SJ; Choi TI; Kim CH; Kim NS
    Gastroenterology; 2021 Mar; 160(4):1194-1207.e28. PubMed ID: 32946903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy.
    Wan X; Pu H; Huang W; Yang S; Zhang Y; Kong Z; Yang Z; Zhao P; Li A; Li T; Li Y
    Oncotarget; 2016 Aug; 7(32):51284-51300. PubMed ID: 27323416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9
    Wang R; Sun Y; Li L; Niu Y; Lin W; Lin C; Antonarakis ES; Luo J; Yeh S; Chang C
    Eur Urol; 2017 Nov; 72(5):835-844. PubMed ID: 28528814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.